Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€15.25
06.05.21
€18.40
06.05.22
23.09%
11.06.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
iBio Inc.

Start price
Target price
Perf. (%)
€33.50
06.05.21
€25.00
06.05.22
-8.77%
28.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€40.55
04.05.21
€55.00
04.05.22
-11.84%
05.05.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Cocrystal Pharma Inc.

Start price
Target price
Perf. (%)
€27.36
04.05.21
€12.00
04.05.22
-39.47%
05.05.21

Could be worthwhile Investment >10% per year
Good culture
Little innovation
buy
Immutep LTD ADR

Start price
Target price
Perf. (%)
€2.70
04.05.21
-
04.05.22
-8.89%
05.05.22

Could be very worthwhile Investment >20% year
buy
Precipio Inc

Start price
Target price
Perf. (%)
€5.51
04.05.21
-
04.05.22
-82.03%
05.05.22

Could be very worthwhile Investment >20% year
buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€71.50
03.05.21
€78.00
03.05.22
2.80%
04.05.22

Could be worthwhile Investment >10% per year
buy
Precipio Inc

Start price
Target price
Perf. (%)
€2.03
03.05.21
€3.00
03.05.22
194.54%
04.05.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
Few uniques
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-41.82%
04.05.22

Could be worthwhile Investment >10% per year
buy
Flexion Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.50
03.05.21
€8.00
03.05.22
2.31%
17.05.21

Could be worthwhile Investment >10% per year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€2.72
03.05.21
€5.00
03.05.22
-5.88%
17.05.21

Could be worthwhile Investment >10% per year
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€4.72
03.05.21
€6.00
03.05.22
-5.93%
17.05.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.90
03.05.21
€10.00
03.05.22
-15.32%
17.05.21

Could be very worthwhile Investment >20% year
buy
Bayer AG

Start price
Target price
Perf. (%)
€53.83
03.05.21
€65.00
03.05.22
13.13%
04.05.22

Differentiated customer and product portfolio
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€23.00
02.05.21
-
02.05.22
-82.60%
03.05.22

Could be worthwhile Investment >10% per year
buy
Haemato AG

Start price
Target price
Perf. (%)
€28.90
02.05.21
€35.00
02.05.22
-4.50%
15.05.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.70
02.05.21
-
02.05.22
1.08%
16.05.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Ascendis Ph.sp.adr 1 Dk 1

Start price
Target price
Perf. (%)
€120.00
02.05.21
€125.00
02.05.22
-28.33%
03.05.22

Could be worthwhile Investment >10% per year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€370.00
01.05.21
-
01.05.22
-5.65%
02.09.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year
buy
Veeva Systems A

Start price
Target price
Perf. (%)
€233.10
01.05.21
€242.00
01.05.22
-26.31%
02.05.22

Could be worthwhile Investment >10% per year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-30.60%
11.06.21

Could be worthwhile Investment >10% per year
Abiomed Inc.

Start price
Target price
Perf. (%)
€266.60
29.04.21
€245.00
29.04.22
-10.43%
07.06.21

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€33.94
29.04.21
-
29.04.26
-29.38%
15.10.21

Could be worthwhile Investment >10% per year
Very high cyclical dependencies